Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker(TM) Technology Targeting Inflammatory Disease

Stock Information for Impact BioMedical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Impact BioMedical Inc.

Impact Biomedical Inc. Announcement Stock Activity/Pricing
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth
Impact Biomedical Inc. Announces Acquisition of Celios®, "Protecting People, Plants, and Animals from the World's Most Dangerous Pathogens With Clean-Room Air Quality"
Impact BioMedical Inc. to Present at The Microcap Conference
Universal Ibogaine Provides Bi-Weekly Default Status Report on Year-End Filings and Update on Belize Property Sale
Universal Ibogaine provides Bi-weekly Default Status Report on year-end filings and update on pending sale of Belize property
Universal Ibogaine advises of Offer to purchase Belize property and update on application for Management Cease Trade Order
Impact BioMedical Inc. Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.